Your browser doesn't support javascript.
loading
Multilevel Proteomic Profiling of Colorectal Adenocarcinoma Caco-2 Cell Differentiation to Characterize an Intestinal Epithelial Model.
Fekete, Emily Ef; Wang, Angela; Creskey, Marybeth; Cummings, Sarah E; Lavoie, Jessie R; Ning, Zhibin; Li, Jianjun; Figeys, Daniel; Chen, Rui; Zhang, Xu.
Affiliation
  • Fekete EE; Regulatory Research Division, Biologic and Radiopharmaceutical Drugs Directorate, Health Products and Food Branch, Health Canada, Ottawa K1A 0K9, Canada.
  • Wang A; Regulatory Research Division, Biologic and Radiopharmaceutical Drugs Directorate, Health Products and Food Branch, Health Canada, Ottawa K1A 0K9, Canada.
  • Creskey M; Regulatory Research Division, Biologic and Radiopharmaceutical Drugs Directorate, Health Products and Food Branch, Health Canada, Ottawa K1A 0K9, Canada.
  • Cummings SE; Regulatory Research Division, Biologic and Radiopharmaceutical Drugs Directorate, Health Products and Food Branch, Health Canada, Ottawa K1A 0K9, Canada.
  • Lavoie JR; Regulatory Research Division, Biologic and Radiopharmaceutical Drugs Directorate, Health Products and Food Branch, Health Canada, Ottawa K1A 0K9, Canada.
  • Ning Z; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa K1H8M5, Canada.
  • Li J; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa K1H8M5, Canada.
  • Figeys D; School of Pharmaceutical Sciences, Faculty of Medicine, University of Ottawa, Ottawa K1H8M5, Canada.
  • Chen R; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, Ontario K1A0R6, Canada.
  • Zhang X; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa K1H8M5, Canada.
J Proteome Res ; 23(7): 2561-2575, 2024 Jul 05.
Article de En | MEDLINE | ID: mdl-38810023
ABSTRACT
Emergent advancements on the role of the intestinal microbiome for human health and disease necessitate well-defined intestinal cellular models to study and rapidly assess host, microbiome, and drug interactions. Differentiated Caco-2 cell line is commonly utilized as an epithelial model for drug permeability studies and has more recently been utilized for investigating host-microbiome interactions. However, its suitability to study such interactions remains to be characterized. Here, we employed multilevel proteomics to demonstrate that both spontaneous and butyrate-induced Caco-2 differentiations displayed similar protein and pathway changes, including the downregulation of proteins related to translation and proliferation and upregulation of functions implicated in host-microbiome interactions, such as cell adhesion, tight junction, extracellular vesicles, and responses to stimuli. Lysine acetylomics revealed that histone protein acetylation levels were decreased along with cell differentiation, while the acetylation in proteins associated with mitochondrial functions was increased. This study also demonstrates that, compared to spontaneous differentiation methods, butyrate-containing medium accelerates Caco-2 differentiation, with earlier upregulation of proteins related to host-microbiome interactions, suggesting its superiority for assay development using this intestinal model. Altogether, this multiomics study emphasizes the controlled progression of Caco-2 differentiation toward a specialized intestinal epithelial-like cell and establishes its suitability for investigating the host-microbiome interactions.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Butyrates / Différenciation cellulaire / Protéomique Limites: Humans Langue: En Journal: J Proteome Res Sujet du journal: BIOQUIMICA Année: 2024 Type de document: Article Pays d'affiliation: Canada

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Butyrates / Différenciation cellulaire / Protéomique Limites: Humans Langue: En Journal: J Proteome Res Sujet du journal: BIOQUIMICA Année: 2024 Type de document: Article Pays d'affiliation: Canada